Autoimmune & Inflammatory

Advancing Autoimmune Clinical Research

Autoimmune diseases affect millions worldwide, causing chronic inflammation, pain, and reduced quality of life. CenExel partners with sponsors to accelerate innovative therapies for autoimmune and inflammatory conditions through expert-driven clinical research, specialized patient recruitment, and experienced investigative sites.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Specialized Autoimmune Clinical Trial Expertise

CenExel provides comprehensive support for autoimmune and inflammatory clinical studies with experienced investigators, advanced recruitment strategies, and patient-centered trial execution. Our research teams are dedicated to improving treatment outcomes across a broad range of autoimmune disorders.

Improve Patient Outcomes

Our experienced physicians and coordinators focus on delivering high-quality patient care throughout every phase of the study.

Accelerate Study Timelines

Efficient site operations and strong patient engagement help sponsors reduce delays and improve enrollment performance.
Conditions Covered

Autoimmune Conditions We Research

Our autoimmune research sites support a wide range of inflammatory and immune-mediated conditions for both adult and pediatric populations.

  • Rheumatoid Arthritis
  • Psoriasis
  • Psoriatic Arthritis
  • Lupus (SLE)
  • Crohn’s Disease
  • Ulcerative Colitis
  • Multiple Sclerosis
  • Ankylosing Spondylitis
Our Approach

Why Sponsors Choose CenExel for Autoimmune Research

CenExel combines scientific expertise, operational excellence, and patient-focused recruitment strategies to help sponsors deliver successful autoimmune clinical trials.

01

Expert Investigators

Our investigators bring extensive experience managing autoimmune and inflammatory conditions across multiple phases of research.

02

Diverse Patient Access

Access to broad and diverse patient populations improves enrollment speed and supports representative clinical outcomes.

03

Advanced Recruitment

Data-driven recruitment strategies help identify and engage qualified autoimmune patients efficiently.

04

High Enrollment Performance

Our sites consistently achieve strong enrollment and retention rates through personalized patient engagement.

Phase Coverage

Supported Autoimmune Trial Phases

CenExel supports early and late-phase autoimmune clinical trials — from first-in-human studies through Phase IV post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our autoimmune research network supports biologics, immunotherapies, and next-generation treatment approaches with experienced operational teams and proven trial execution.

Autoimmune Task Force

CenExel supports autoimmune and inflammatory studies with specialized investigators, experienced coordinators, and diverse patient populations across multiple therapeutic areas.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog